ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10400JMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10413CMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10420KMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10955NMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 10961XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12328WMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12329XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12330YMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
2 | 4 | 5 | $979.46 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12334EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12352DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12353EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12355GMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $444.17 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12356HMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12368YMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $470.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12369BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
2 | 4 | 5 | $979.46 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12370CMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12385WMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
2 | 4 | 2 | $979.46 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12386XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12388BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12401QMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12402RMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
3 | 6 | 0 | $1464.78 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12403TMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12415KMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12420QMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13686HMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13692PMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13754XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14261NMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14262PMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14263QMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 14284TMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 6 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 5282BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 5284DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8965WMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 8966XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9099XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9100YMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9101BMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9102CMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9103DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 3 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9104EMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9190QMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 2 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9191RMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9426DMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 4 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | General Schedule |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9428FMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $494.12 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | S100 HSD Public |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9663NMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $444.17 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
ADALIMUMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 9680LMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $470.82 | $31.60 | $31.60 |
| Available brands | |||||||
| Abriladaa | |||||||
| Amgevitaa | |||||||
| Hadlimaa | |||||||
| Hyrimoza |
- Legend
- aBrand equivalent a
- MPMedical Practitioner




